266 related articles for article (PubMed ID: 38317930)
21. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
22. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
23. Mapping of microRNAs related to cervical cancer in Latin American human genomic variants.
Guerrero Flórez M; Guerrero Gómez OA; Mena Huertas J; Yépez Chamorro MC
F1000Res; 2017; 6():946. PubMed ID: 37766816
[No Abstract] [Full Text] [Related]
24. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
25. Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.
Gómez-Gómez Y; Organista-Nava J; Gariglio P
Biomed Res Int; 2013; 2013():407052. PubMed ID: 24490161
[TBL] [Abstract][Full Text] [Related]
26. A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis.
Shaw P; Senthilnathan R; Sankar S; Ilangovan I; Kodiveri Muthukaliannan G; Baxi S; Mani RR; Rajagopal M; Chinnappan S; Balaraman AK; Suresh D; Krishnan S; Gupta M; Muthusamy T; Paranjothy C; Jayaraj R
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328017
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
Seyhan AA
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
[TBL] [Abstract][Full Text] [Related]
28. Role of microRNAs as biomarkers of cervical carcinogenesis: a systematic review.
Nagandla K; Lin KH; Chitra E; Jamli MFBM
Obstet Gynecol Sci; 2021 Sep; 64(5):419-436. PubMed ID: 34384196
[TBL] [Abstract][Full Text] [Related]
29. Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age.
Kotani K; Iwata A; Kukimoto I; Nishio E; Mitani T; Tsukamoto T; Ichikawa R; Nomura H; Fujii T
Sci Rep; 2022 Sep; 12(1):16231. PubMed ID: 36171233
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
31. Identification of autophagy-associated miRNA signature for the cervical squamous cell cancer and high-grade cervical intraepithelial lesions.
Bayramoglu Tepe N; Bozgeyik E; Bozdag Z; Balat O; Ozcan HC; Ugur MG
Reprod Biol; 2021 Sep; 21(3):100536. PubMed ID: 34298410
[TBL] [Abstract][Full Text] [Related]
32. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
33. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.
Babion I; Snoek BC; Novianti PW; Jaspers A; van Trommel N; Heideman DAM; Meijer CJLM; Snijders PJF; Steenbergen RDM; Wilting SM
Clin Epigenetics; 2018; 10():76. PubMed ID: 29930741
[TBL] [Abstract][Full Text] [Related]
34. Potential role of microRNAs in the treatment and diagnosis of cervical cancer.
Shen S; Zhang S; Liu P; Wang J; Du H
Cancer Genet; 2020 Oct; 248-249():25-30. PubMed ID: 32987255
[TBL] [Abstract][Full Text] [Related]
35. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
[TBL] [Abstract][Full Text] [Related]
36. Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.
Chen S; Gao C; Wu Y; Huang Z
Front Pharmacol; 2020; 11():544. PubMed ID: 32457603
[TBL] [Abstract][Full Text] [Related]
37. Cervical Cancer, Papillomavirus, and miRNA Dysfunction.
Bañuelos-Villegas EG; Pérez-yPérez MF; Alvarez-Salas LM
Front Mol Biosci; 2021; 8():758337. PubMed ID: 34957212
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Exosomal miRNA as Potential Biomarkers in Cervical Cancer.
do Nascimento Medeiros JA; Sarmento ACA; Bernardes-Oliveira E; de Oliveira R; Lima MEGB; Gonçalves AK; de Souza Dantas D; de Oliveira Crispim JC
Epigenomes; 2023 Aug; 7(3):. PubMed ID: 37606453
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.
Pedroza-Torres A; López-Urrutia E; García-Castillo V; Jacobo-Herrera N; Herrera LA; Peralta-Zaragoza O; López-Camarillo C; De Leon DC; Fernández-Retana J; Cerna-Cortés JF; Pérez-Plasencia C
Molecules; 2014 May; 19(5):6263-81. PubMed ID: 24840898
[TBL] [Abstract][Full Text] [Related]
40. Highly expressed circ_0000285 from serum and cervical exfoliated cells as a novel biomarker for the diagnosis of early stage-cervical cancer.
Chen H; Tian X; Luan Y; Lu H
J Obstet Gynaecol; 2023 Dec; 43(1):2196344. PubMed ID: 37029728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
